Floatz logo

Lidocaine

Diverticulitis

Franco CarliSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Diverticulitis cohort.

Asset / SponsorPhaseRating
Marcaine
Des Moines University
Phase 4BBB
Hextend
Corewell Health West
Phase 3BB
Nepenthe
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 1/2CCC
Vandazole
Thomas Jefferson University
Early Phase 1C
Neomycin
Thomas Jefferson University
Early Phase 1C
Macrogols
Thomas Jefferson University
Early Phase 1C
Caffeine
Thomas Steffen
N/AD

Same molecule, other indications

Lidocaine is also rated in:

peripheral neuropathyActive
BBB
Indicative · Phase 4
79 / 100
View asset →
postherpetic neuralgiaDormant
BBB
Indicative · Phase 4
78 / 100
View asset →
post-operative pain, non-human animalActive
BBB
Indicative · Phase 4
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →